
|Podcasts|September 4, 2019
Mapping Multiple Myeloma Advances in NYC
Author(s)Onclive Team
We traveled to New York City, New York, for a State of the Science Summit™ on Multiple Myeloma, which featured insights from the faculty from the Mount Sinai Hospital.
Advertisement
We recently traveled to New York City, New York, for a State of the Science Summit™ on Multiple Myeloma. We met with experts from Mount Sinai Hospital to gather updates on emerging treatment strategies in multiple myeloma, including headway made with CAR T-cell therapies, the role of genomics, the shift toward personalized medicine, and progress made with maintenance therapies.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on OncLive
1
FDA Grants Priority Review to Frontline Dato-DXd for Metastatic TNBC Ineligible for Immunotherapy
2
Leveraging AI for Optimal Clinical Trial Design in Oncology
3
Retrospective, Real-World Analysis Shows Improved OS With Apalutamide Over Darolutamide in mCSPC
4
Latest ACS Cancer Statistics Report Outlines Notable Gains, Remaining Gaps Across Tumor Types
5



































